Molecular Imaging Agents

Our products and solutions help healthcare providers and therapy innovators to make more informed and earlier diagnosis, monitor disease more accurately and develop tailored patient treatment plans across major care pathways.
Support

Adverse events reporting

Adverse events should be reported
Reporting forms and information can be found at: http://www.mhra.gov.uk/yellowcard
Adverse events should also be reported to GE HealthCare at:
GPV.drugsafety@gehealtcare.com

Products

DaTSCAN

Rapiscan

SeHCAT

Please see DaTSCAN™ ioflupane (123I) prescribing information for Great Britain here.

Please see DaTSCAN™ ioflupane (123I) prescribing information for Northern Ireland here.

Please see Rapiscan™ (regadenoson) prescribing information here.

Please see SeHCAT™ [75Se]tauroselcholic acid prescribing information here.

Please see Myoview™ (Technetium (99mTc) Tetrofosmin) prescribing information here.

JB03410UK